Nasopharyngeal swabs and their ability to collect mucus and saliva and release them into the transport medium with a high recovery rate are of paramount importance in the detection of bacterial and viral infections. The US FDA and CDC recommend polyurethane foam swabs for PCR detection of most respiratory viruses including SARS-CoV-2 (COVID-19), rhinoviruses and enteroviruses (Picornaviridae), influenza viruses (Orthomyxoviridae), parainfluenza, metapneumoviruses and respiratory syncytial viruses (Paramyxoviridae), coronaviruses (Coronaviridae) and bacterial infections caused by Streptococcus pneumoniae (pneumonia) and Streptococcus pyogenes (strep throat).
Foamtec Medical Nasopharyngeal swabs utilize Foamtec developed polyurethane foam technology that provides an exceptional surface area to capture a maximum quantity of target fluids, while not bonding to those fluids providing high subject recovery.
Foamtec Medical proprietary swab cleaning processes and validated sterility ensure no background from RNAse and other contaminants for accurate test results. While providing precise results, comfort in Nasopharyngeal swabbing is achieved with long, slender, flexible handles keeping patient discomfort to a minimum while reaching remote areas of the nasal septum and oral cavities.
• High surface area captures maximum amount of mucus and saliva.
• No bonding to swabbed body fluids.
• Validated sterile, clean swab surfaces.
• Thin, high flexibility handles.
• Ability to reach remote areas of the nasal septum and oral cavities.
• High recovery rates of body fluids for accurate test results.
• Maximum patient comfort.